Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Psychosocial Stress Raises Risk of Dementia and Stroke
February 2026
Cumulative psychosocial stress across childhood and adulthood is linked to higher dementia and stroke risk, partly driven by depression.
Read more
13 Dec 2016
Clinical Management of Drug-Induced Dyskinesia in Parkinson’s Disease: Why Current Approaches May Need to Be Changed to Optimise Quality of Life
Parkinson’s disease is a complex, progressive neurodegenerative disorder associated with both motor and non-motor symptoms. Current treatment strategies…
12 Dec 2016
Enzyme Deficiency Provides New Treatment Target for Prader-Willi Syndrome
DEFICIENCY of the prohormone covertase (PC1) enzyme in the brain has been linked to the neuro-hormonal abnormalities found in patients with Prader-Willi…
8 Dec 2016
Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop Innovative Therapy for Patients with ALS
Germany, December 07, 2016 – Neurimmune and TVM Capital Life Science’s latest fund, TVM Life Science Ventures VII, today announced their investment in…
8 Dec 2016
Promising Drug Trial Results for Infant Spinal Muscular Atrophy Treatment
THE INTERIM results of a small, ongoing Phase II trial have shown that the drug nusinersen is a well-tolerated treatment for infantile-onset spinal…
5
Mins
5 Dec 2016
An Interview with Merck’s Chief Marketing Officer About Upcoming WE100 Project
This interview took place at the Ageing Societies event held by The Economist, earlier this year in November.
29 Nov 2016
Astronauts’ Visual Impairment Involves Changes in Cerebrospinal Fluid
OCULAR impairments experienced by astronauts are linked to space-induced volume changes in cerebrospinal fluid (CSF), according to research presented…
24 Nov 2016
Experts Fear Kanye West’s Breakdown is a Symptom of An Unchecked Mental Illness
According to news early this week, American rapper, songwriter, record producer, fashion designer, entrepreneur and notorious workaholic, Kanye West has…
24 Nov 2016
Retrieval Practice Offers Protection from Stress-Related Memory Loss
THE RESULTS of a new study have shown that retrieval practice (RP) is an effective strategy for protecting against memory impairment caused by stress.
Loading posts...
« Previous
1
…
93
94
95
96
97
…
105
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View